Brian A. Pollok, Ph.d.
Co-Founder, President and CEO
pharmaceutical
Propagenix
United States of America
Biography
Dr. Pollok has 30 years of career experience in the pharmaceutical/biotechnology sector. Past positions include serving as President of ATCC, CSO of Life Technologies, SVP and co-founder of Ansata Therapeutics, VP of Discovery Biology at Aurora Biosciences/Vertex Pharmaceuticals, Sr. Research Investigator at Pfizer Central Research, and as Assistant Professor of Immunology at Wake Forest University. He also currently serves as a board director to Virginia BIO and UVA's Licensing & Ventures Group, and is a member of Cure SMA's Translational Research Advisory Council.
Research Interest
The company is dedicated to continuing to develop Propagenix technology for a wide range of applications in basic and translational biomedical research. Our vision is to enable the creation of new and more effective drugs, personalized diagnostics and cell therapies that will enhance human healthcare.
